1 / 14

Carotenoids and Lung Cancer Publication

Carotenoids and Lung Cancer Publication. M ä nnist ö , S., et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiology, Biomarkers and Prevention, 2004; 13: 40-48.

sumi
Download Presentation

Carotenoids and Lung Cancer Publication

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Carotenoids and Lung Cancer Publication Männistö, S., et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiology, Biomarkers and Prevention, 2004; 13: 40-48.

  2. Cohort Studies Included in the Pooled Analysis of Carotenoids and Lung Cancer Nurses’ Health Study Netherlands Cohort Study Canadian National Breast Screening Study Health Professionals Follow-up Study New York State Cohort Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Total = 399,765 # cases = 3,155 Iowa Women’s Health Study Männistö, et al. 2004

  3. Cohort Studies in the Pooled Analysis of Carotenoids and Lung Cancer Study Baseline # of Cohort Cases ATBC 6,771 298 Canadian National 56,837 149 Health Professionals 44,350 244 Iowa Women’s 33,828 433 Netherlands Cohort (W) 62,412 131 Netherlands Cohort (M) 58,279 843 New York State (W) 21,045 130 New York State (M) 27,936 392 Nurses’ Health (a) 88,307 156 Nurses’ Health (b) 68,307 379 Männistö, et al. 2004

  4. Mean Carotenoid Intakes (mcg/d) Study Alpha- Beta- Beta- carotene carotene cryptoxanthin ATBC 527 1758 25 Canadian National 986 4619 79 Health Professionals 980 5159 88 Iowa Women’s 773 4527 74 Netherlands Cohort (W) 685 2901 206 Netherlands Cohort (M) 687 2960 155 New York State (W) 1144 6346 247 New York State (M) 1171 6382 215 Nurses’ Health (a) 723 4424 104 Nurses’ Health (b) 764 4273 62 Männistö, et al. 2004

  5. Mean Carotenoid Intakes (mcg/d) (cont’d) Study Lutein/ Lycopene Zeaxanthin ATBC 1146 645 Canadian National 3037 8891 Health Professionals 3949 10844 Iowa Women’s 2795 4180 Netherlands Cohort (W) 2448 1303 Netherlands Cohort (M) 2550 1045 New York State (W) 5998 5683 New York State (M) 6025 7274 Nurses’ Health (a) 5086 5255 Nurses’ Health (b) 3531 9643 Männistö, et al. 2004

  6. Alpha- and Beta-Carotene and Lung Cancer: Pooled Multivariate Relative Risks by Quintile Quintile Alpha- Beta- carotene carotene 1 1.00 1.00 2 0.91 (0.80-1.05) 0.97 (0.82-1.16) 3 0.94 (0.84-1.06) 1.00 (0.84-1.20) 4 0.95 (0.84-1.07) 0.94 (0.82-1.08) 5 0.93 (0.82-1.06) 0.98 (0.87-1.11) p for trend 0.47 0.47 p for het. for Q5 0.39 0.85 Männistö, et al. 2004

  7. Lutein and Lycopene and Lung Cancer: Pooled Multivariate Relative Risks by Quintile Quintile Lutein/ Lycopene Zeaxanthin 1 1.00 1.00 2 0.98 (0.87-1.10) 0.86 (0.75-0.97) 3 0.92 (0.79-1.06) 0.85 (0.74-0.99) 4 0.97 (0.86-1.10) 0.88 (0.77-1.01) 5 0.91 (0.81-1.03) 0.91 (0.78-1.07) p for trend 0.15 0.42 p for het. for Q5 0.81 0.11 Männistö, et al. 2004

  8. Beta-Cryptoxanthin and Lung Cancer: Pooled Relative Risks by Quintile Quintile Age-adjusted Multivariate 1 1.00 1.00 2 0.71 (0.64-0.80) 0.90 (0.80-1.00) 3 0.59 (0.51-0.69) 0.83 (0.71-0.96) 4 0.56 (0.48-0.64) 0.86 (0.76-0.97) 5 0.50 (0.43-0.57) 0.76 (0.67-0.86) p for trend <0.001 <0.001 p for het. for Q5 0.27 0.95 Männistö, et al. 2004

  9. Pooled Multivariate Relative Risks for Lung Cancer by Categories of Beta-Cryptoxanthin Relative Risk Männistö, et al. 2004

  10. Study-Specific Multivariate RRs (Quintile 5 vs. 1) for Beta-Cryptoxanthin and Lung Cancer Männistö, et al. 2004

  11. Beta-Cryptoxanthin and Lung Cancer: Pooled Multivariate Relative Risks by Smoking Status Quartile Never Past Current n=259 n=981 n=1915 1 1.00 1.00 1.00 2 0.74 0.80 0.84 3 0.79 0.93 0.87 4 0.77 0.84 0.70 (0.42-1.42) (0.69-1.03) (0.60-0.81) p for trend 0.80 0.43 <0.001 p for het. due to smoking status for Q4 = 0.30 Männistö, et al. 2004

  12. Beta-Cryptoxanthin and Lung Cancer: Pooled Multivariate Relative Risks by Cell Type Quartile Adeno. Small Squamous n=956 n=538 n=901 1 1.00 1.00 1.00 2 0.79 0.84 0.71 3 0.86 0.74 0.76 4 0.80 0.66 0.67 (0.68-0.93) (0.51-0.87) (0.56-0.80) p for trend 0.01 0.02 <0.001 p for common effects by cell type for Q4 = 0.24 Männistö, et al. 2004

  13. Beta-Carotene and Lung Cancer: Pooled Multivariate Relative Risks by Smoking Status Quartile Never Past Current n=259 n=981 n=1915 1 1.00 1.00 1.00 2 1.11 0.88 1.01 3 0.98 0.86 0.98 4 1.02 1.06 0.98 (0.70-1.47) (0.86-1.32) (0.84-1.14) p for trend 0.73 0.61 0.62 p for het. due to smoking status for Q4 = 0.83 Männistö, et al. 2004

  14. Beta-Carotene and Lung Cancer: Pooled Multivariate Relative Risks by Cell Type Quartile Adeno. Small Squamous n=956 n=538 n=901 1 1.00 1.00 1.00 2 0.98 1.13 0.88 3 1.03 1.03 0.96 4 1.04 1.18 1.06 (0.85-1.27) (0.97-1.43) (0.89-1.27) p for trend 0.84 0.21 0.50 p for common effects by cell type for Q4 = 0.66 Männistö, et al. 2004

More Related